Global contraceptive market expected to reach approximately USD 16.25 billion by 2021, growing at a CAGR of 4.00% between 2016 and 2021.

Sarasota, FL -- (SBWire) -- 03/14/2017 --Zion Market Research has published a new report titled "Contraceptive Market by Method Type (Contraceptive Pills, Injectables, Female Sterilization, Intrauterine Devices & Systems, Male Condom, Emergency Contraception and Others) - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021'.' According to the report, the global contraceptive market accounted for around USD 12.75 billion in 2015 and is expected to reach approximately USD 16.25 billion by 2021, growing at a CAGR of around 4.00% between 2016 and 2021.

Request Free Sample Research Report @ https://www.zionmarketresearch.com/sample/contraceptive-market

Contraception is the prevention of pregnancy by contraceptive methods other than abstinence and it is used to limit the size of the family. The percentage of women using contraceptives methods has increased in both developed and developing countries, in the last two decades. This has increased women's opportunities to choose when and how many children they want to have, which has a positive impact not only on their rights to education but also on their right to health, an adequate standard of living amongst other human rights and work. Use of contraceptive methods for family planning reduces the numbers of risky and unintended pregnancies, which in turn reduces the risks of long-term morbidity and maternal mortality. But still, more than 222 million women in developing countries do not have access to modern contraceptives.

According to World Health Organization, every day more than 1 million people across the globe are getting affected by sexually transmitted infections (STIs). Sexually transmitted infections are the major burden of diseases and have negative effects on people health. Chlamydia, Syphilis and Gonorrhoea are three sexually transmitted infections which are all caused by bacteria and which can be cured by antibiotics treatment. Thus, widely increasing the prevalence of sexually transmitted infections is continuously responsible for the growth of the contraceptive market. Moreover, according to the World Health Organization, there were approximately more than 36 million people living with HIV and around 1.10 million people died from AIDS-related illnesses in 2015. HIV/AIDS is the leading cause of death for women in their reproductive years. In 2014, more than 70% of pregnant women infected with HIV are using antiretroviral medicines to prevent the transmission of HIV/AIDS to their children but still more than1.8 million children are living with HIV. Almost all of these children were infected by their HIV-infected mothers during childbirth, pregnancy or breastfeeding. Thus, rapidly increasing HIV-positive population is driving the market of contraceptive market. The contraceptive market is also growing with the new emerging products and technologies of contraception. However, cast-driven traditional fundamentals and increasing the prevalence of side effects due to improper use of contraception products may hamper the growth contraceptive market. Nonetheless, untapped market and increasing awareness towards women health & family planning are projected to generate new opportunities in forecast years for the contraceptive market.

Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/contraceptive-market

Based on the method type, the market of contraceptive has been classified into contraceptive pills, injectables, female sterilization, intrauterine devices & systems, male condom, emergency contraception and other. Male condom and contraceptive pills are useful to prevent an unintended pregnancy and child birth. Contraceptive pills are 97% effective at preventing pregnancy. Contraceptive pills are very effective against pregnancy if used correctly, makes menstrual periods more regular and lighter, decreases menstrual cramps & acne and does not interfere with spontaneity. Thus due to increasing use, contraceptive pills segments dominated the market and it is expected to exhibit noticeable growth in the forecast period. Female sterilization contraceptive method is one of the permanent, long lasting and highly effective solutions for the pregnancy or birth control and it has around 99.5% effectiveness at preventing pregnancy. Older women are more likely to rely on sterilization than younger women. Thus, female sterilization segment is the second largest segment of the contraceptive market with more than 25% market share in 2015.

The contraceptive market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. As a result of increasing demand for contraceptive North America has the strong hold on the contraceptive market with around 35% share. Asia-Pacific is expected to show noticeable growth in the forecast period, as a result, increasing women population.

Key operating players in the contraceptive market are like The Female Health Company, Teva Pharmaceutical Industries, Bayer Healthcare Pharmaceuticals, Piramal Healthcare Limited, Reckitt Benckiser Plc., Cipla Limited, Novartis AG, Lupin Pharmaceuticals, Inc, Pfizer, Inc., Amgen Inc., Sun Pharmaceutical Industries Ltd., and Glenmark Pharmaceuticals.

Browse detail report with in-depth TOC @ https://www.zionmarketresearch.com/report/contraceptive-market

Contraceptive Market: Method Type Analysis

Contraceptive Pill
Injectable
Female Sterilization
Intrauterine devices and systems
Male Condom
Emergency contraception
Other

Contraceptive Market: Regional Type Analysis

North America
Europe
Asia Pacific
Latin America
The Middle East and Africa

Request a customized copy of report @ https://www.zionmarketresearch.com/custom/368